These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2323837)

  • 21. Multidrug resistance proteins in rhabdomyosarcomas: comparison between children and adults.
    Komdeur R; Klunder J; van der Graaf WT; van den Berg E; de Bont ES; Hoekstra HJ; Molenaar WM
    Cancer; 2003 Apr; 97(8):1999-2005. PubMed ID: 12673730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
    Bourhis J; De Vathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; McNally NJ; Lemerle J; Riou G; Bénard J
    Cancer Res; 1991 Jan; 51(1):33-6. PubMed ID: 1988094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma.
    Ragazzini P; Gamberi G; Pazzaglia L; Serra M; Magagnoli G; Ponticelli F; Ferrari C; Ghinelli C; Alberghini M; Bertoni F; Picci P; Benassi MS
    Histol Histopathol; 2004 Apr; 19(2):401-11. PubMed ID: 15024701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
    Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD
    Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosome 2 abnormalities (+Der 2) in two cases of childhood rhabdomyosarcoma.
    Vagner-Capodano AM; Gentet JC; Gouzien M; Scheiner C; Raybaud C
    Pediatr Hematol Oncol; 1989; 6(2):187-92. PubMed ID: 2702073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.
    Kuda M; Kohashi K; Yamada Y; Maekawa A; Kinoshita Y; Nakatsura T; Iwamoto Y; Taguchi T; Oda Y
    Tumour Biol; 2016 Apr; 37(4):5213-23. PubMed ID: 26553361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of alveolar rhabdomyosarcoma copy number alterations by single nucleotide polymorphism analysis.
    Lynn M; Shah N; Conroy J; Ennis S; Morris T; Betts D; O'Sullivan M
    Appl Immunohistochem Mol Morphol; 2014 Mar; 22(3):213-21. PubMed ID: 24614150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A study of amplifications of myc gene (c-myc and N-myc) in human ovarian cancer].
    Kataoka A; Yakushiji M; Kojiro M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Mar; 42(3):259-63. PubMed ID: 2332674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer].
    Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of an embryonal rhabdomyosarcoma cell line showing amplification and over-expression of the N-myc oncogene.
    Hayashi Y; Sugimoto T; Horii Y; Hosoi H; Inazawa J; Kemshead JT; Inaba T; Hanada R; Yamamoto K; Gown AM
    Int J Cancer; 1990 Apr; 45(4):705-11. PubMed ID: 2323848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization.
    Weber-Hall S; Anderson J; McManus A; Abe S; Nojima T; Pinkerton R; Pritchard-Jones K; Shipley J
    Cancer Res; 1996 Jul; 56(14):3220-4. PubMed ID: 8764111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between MYCN copy number and expression in rhabdomyosarcomas and correlation with adverse prognosis in the alveolar subtype.
    Williamson D; Lu YJ; Gordon T; Sciot R; Kelsey A; Fisher C; Poremba C; Anderson J; Pritchard-Jones K; Shipley J
    J Clin Oncol; 2005 Feb; 23(4):880-8. PubMed ID: 15681534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.
    Missiaglia E; Selfe J; Hamdi M; Williamson D; Schaaf G; Fang C; Koster J; Summersgill B; Messahel B; Versteeg R; Pritchard-Jones K; Kool M; Shipley J
    Genes Chromosomes Cancer; 2009 Jun; 48(6):455-67. PubMed ID: 19235922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rhabdomyosarcoma: cytogenetics of five cases using fine-needle aspiration samples and review of the literature.
    Udayakumar AM; Sundareshan TS; Appaji L; Biswas S; Mukherjee G
    Ann Genet; 2002; 45(1):33-7. PubMed ID: 11934388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction.
    Stratton MR; Fisher C; Gusterson BA; Cooper CS
    Cancer Res; 1989 Nov; 49(22):6324-7. PubMed ID: 2680062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in childhood rhabdomyosarcoma.
    San Miguel-Fraile P; Carrillo-Gijón R; Rodriguez-Peralto JL; Badiola IA
    Am J Clin Pathol; 2004 Mar; 121(3):358-65. PubMed ID: 15023040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence: clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study.
    Leuschner I; Langhans I; Schmitz R; Harms D; Mattke A; Treuner J;
    Pediatr Dev Pathol; 2003; 6(2):128-36. PubMed ID: 12574910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas.
    Gattenloehner S; Dockhorn-Dworniczak B; Leuschner I; Vincent A; Müller-Hermelink HK; Marx A
    J Mol Diagn; 1999 Nov; 1(1):23-31. PubMed ID: 11272905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
    Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
    J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-myc and c-myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c-myc amplification.
    Badiali M; Pession A; Basso G; Andreini L; Rigobello L; Galassi E; Giangaspero F
    Tumori; 1991 Apr; 77(2):118-21. PubMed ID: 2048223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.